Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Annals of Oncology ◽

10.1093/annonc/mdw370.95 ◽

2016 ◽

Vol 27 ◽

pp. vi180

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Satake ◽

Y. Miyamoto ◽

H. Tanioka ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-1558 ◽

2017 ◽

Vol 24 (2) ◽

pp. 316-325 ◽

Author(s):

Axel Grothey ◽

Jonathan R. Strosberg ◽

Lindsay A. Renfro ◽

Herbert I. Hurwitz ◽

John L. Marshall ◽

...

Keyword(s):

Colorectal Cancer ◽

Supportive Care ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Best Supportive Care ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.10127 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 10127-10127 ◽

Author(s):

Yuji Miyamoto ◽

Satoshi Yuki ◽

Mototsugu Shimokawa ◽

Hiroaki Tanioka ◽

Akihito Tsuji ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2013.04.001 ◽

2013 ◽

Vol 12 (3) ◽

pp. 218-222 ◽

Author(s):

Johanna C. Bendell ◽

Thomas J. Ervin ◽

David Gallinson ◽

Jaswinder Singh ◽

James A. Wallace ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Study Design ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2767-y ◽

2015 ◽

Vol 76 (1) ◽

pp. 97-103 ◽

Author(s):

Chu Matsuda ◽

Yoshinori Munemoto ◽

Hideyuki Mishima ◽

Naoki Nagata ◽

Mitsuru Oshiro ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Cancer Chemotherapy ◽

Oral Mucositis ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Phase Ii

Download Full-text

2111 A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31033-4 ◽

2015 ◽

Vol 51 ◽

pp. S366 ◽

Author(s):

J. Li ◽

R. Xu ◽

Y. Bai ◽

J. Xu ◽

T. Liu ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase

Download Full-text

6005 ORAL A Multicenter, Randomized, Double-blind, Phase II Study of TAS-102 (A) Plus Best Supportive Care (BSC) Versus Placebo (P) Plus BSC in Patients (pts) With Chemotherapy-refractory Metastatic Colorectal Cancer (mCRC)

European Journal of Cancer ◽

10.1016/s0959-8049(11)71650-1 ◽

2011 ◽

Vol 47 ◽

pp. S392 ◽

Author(s):

Y. Kuboki ◽

T. Yoshino ◽

K. Yamazaki ◽

T. Nishina ◽

Y. Komatsu ◽

...

Keyword(s):

Colorectal Cancer ◽

Supportive Care ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Best Supportive Care ◽

Download Full-text

Double-Blind, Placebo-Controlled, Randomized Phase II Study of TJ-14 (Hangeshashinto) for Infusional Fluorinated-Pyrimidine-based Colorectal Cancer Chemotherapy-induced Oral Mucositis

Annals of Cancer Research and Therapy ◽

10.4993/acrt.21.26 ◽

2013 ◽

Vol 21 (1) ◽

pp. 26-30 ◽

Author(s):

Chu Matsuda ◽

Toru Kono ◽

Yoshinori Munemoto ◽

Naoki Nagata ◽

Masato Kataoka ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Cancer Chemotherapy ◽

Oral Mucositis ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Phase Ii

Download Full-text

A double-blind, randomized, placebo-controlled, phase II study of maintenance enzastaurin with 5-FU/leucovorin plus bevacizumab following first-line therapy for metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.3527 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 3527-3527 ◽

Author(s):

R. A. Wolff ◽

W. Schepp ◽

M. Di Bartolomeo ◽

A. Hossain ◽

C. Stoffregen ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

First Line Therapy ◽

Download Full-text

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

Journal of Hematology & Oncology ◽

10.1186/s13045-016-0384-9 ◽

2017 ◽

Vol 10 (1) ◽

Author(s):

Rui-Hua Xu ◽

Jin Li ◽

Yuxian Bai ◽

Jianming Xu ◽

Tianshu Liu ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Safety And Efficacy ◽

Phase Ib ◽

Previously Treated

Download Full-text

A Randomized, Double‐Blind , Placebo‐Controlled , Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study

The Oncologist ◽

10.1634/theoncologist.2020-0679 ◽

2020 ◽

Vol 25 (11) ◽

Author(s):

Richard F. Riedel ◽

Karla V. Ballman ◽

Yao Lu ◽

Steven Attia ◽

Elizabeth T. Loggers ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Refractory

Download Full-text